Plus Therapeutics (PSTV) Misses Q2 EPS by 71c
Plus Therapeutics (NASDAQ: PSTV) reported Q2 EPS of ($0.71). Revenue for the quarter came in at $1.27 million.
For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.
Plus Therapeutics (NASDAQ: PSTV) reported Q2 EPS of ($0.71). Revenue for the quarter came in at $1.27 million.
For earnings history and earnings-related data on Plus Therapeutics (PSTV) click here.